Volume | 1,213,504 |
|
|||||
News | - | ||||||
Day High | 25.965 | Low High |
|||||
Day Low | 25.60 |
Etf Name | Etf Symbol | Market | Stock Type |
---|---|---|---|
ARK Genomic Revolution ETF | ARKG | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
25.77 | 25.60 | 25.965 | 25.63 | 25.66 |
Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
12,003 | 1,213,504 | 25.80 | 31,304,406 | - | 21.97 - 38.97 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
19:00:00 | 15,842 | 25.63 | USD |
ARK Genomic Revolution ETF (ARKG) Options Flow Summary
ARK Genomic Revolution ETF Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.44B | - | - | - | 39.54 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News ARK Genomic Revolution ETF
Date | Time | Source | Heading |
---|---|---|---|
12/04/2023 | 06:00 | PR Newswire (Canada) | L'émission Strictly Money, commanditée par les FNB BMO et.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
ARKG Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 26.63 | 26.73 | 25.29 | 26.19 | 2,050,023 | -1.07 | -4.02% |
1 Month | 22.99 | 27.78 | 22.6565 | 25.38 | 2,751,094 | 2.57 | 11.18% |
3 Months | 31.35 | 32.315 | 22.62 | 26.41 | 2,419,137 | -5.79 | -18.47% |
6 Months | 27.66 | 34.37 | 22.62 | 28.77 | 2,762,430 | -2.10 | -7.59% |
1 Year | 32.47 | 38.97 | 21.97 | 29.04 | 2,233,992 | -6.91 | -21.28% |
3 Years | 78.79 | 94.14 | 21.97 | 43.08 | 2,514,469 | -53.23 | -67.56% |
5 Years | 30.51 | 115.15 | 21.97 | 55.35 | 2,100,529 | -4.95 | -16.22% |
The investment seeks longterm growth of capital. The fund is an activelymanaged exchangetraded fund ETF that will invest under normal circumstances primarily at least 80% of its assets in domestic and foreign equity securities of companies across multiple sectors including healthcare information technology materials energy and consumer discretionary that are relevant to the funds investment theme of the genomics revolution Genomics Revolution Companies. It is nondiversified. The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the funds investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified. |